Results 151 to 160 of about 32,506 (196)

Carpal tunnel syndrome, spinal canal stenosis, cardiomyopathy, renal insufficiency, enteropathy, and diffuse myopathy as an expression of systemic ATTR amyloidosis - diagnostics and therapy. [PDF]

J Surg Case Rep
Radmer S, Andresen JR.
europepmc   +1 more source

Correction to: Conventional heart failure therapy in cardiac ATTR amyloidosis. [PDF]

Eur Heart J
europepmc   +1 more source

Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M) [PDF]

Journal of Nephrology, 2003
Abstract Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M) is the most common form of systemic hereditary amyloidosis, inherited in autosomal dominant mode. The disease, also called familial amyloid polyneuropathy type I (FAP-I), is caused by a mutant transthyretin (TTR) protein, which is synthesized by the liver.
Lobato, L.
openaire   +3 more sources

Therapy of ATTR Cardiac Amyloidosis: Current Indications

Current Problems in Cardiology, 2023
Transthyretin cardiac amyloidosis is a restrictive cardiomyopathy caused by extracellular deposition in the heart of amyloid fibrils derived from plasma transthyretin (ATTR), either in its hereditary (ATTRh) or acquired (ATTRwt) forms. Cardiac amyloidosis has a very poor prognosis if therapy is not started promptly.
Di Lisi, Daniela, Di Stefano, Vincenzo, Brighina, Filippo, Galassi, Alfredo Ruggero, Novo, Giuseppina   +4 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Targeted treatments of AL and ATTR amyloidosis

Heart Failure Reviews, 2021
The therapeutic landscape for cardiac amyloidosis is rapidly evolving. In the last decade, our focus has shifted from dealing with the inevitable complications of continued extracellular infiltration of amyloid fibrils to earlier identification of these patients with prompt initiation of targeted therapy to prevent further deposition.
Pranav, Chandrashekar, Anish K, Desai, Barry H, Trachtenberg   +2 more
openaire   +2 more sources

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy [PDF]

Journal of Neurology, 2020
Amyloid transthyretin (ATTR) amyloidosis with polyneuropathy (PN) is a progressive, debilitating, systemic disease wherein transthyretin protein misfolds to form amyloid, which is deposited in the endoneurium. ATTR amyloidosis with PN is the most serious
Julian Gillmore, Giampaolo Merlini, João Beirao   +2 more
exaly   +3 more sources

Erythropoietin in Familial Amyloidosis ATTR V30M

, 2013
Familial amyloidosis ATTR V30M is an hereditary disorder, the most frequent type of transthyretin related amyloidosis. The main manifestation of the disease is a sensory-motor and autonomic polyneuropathy.
Costa, P.P., Beirão, I.
openaire   +2 more sources

The Swedish landscape of hereditary ATTR amyloidosis

Amyloid, 2017
Northern Sweden is a well-known clustering area for hereditary transthyretin (TTR) amyloid (ATTR) amyloidosis caused by the Val30Met mutation.
Ole B, Suhr, Jonas, Wixner, Björn, Pilebro, Hans-Erik, Lundgren, Intissar, Anan   +4 more
openaire   +2 more sources

Myelopathy in hereditary ATTR Val30Met amyloidosis patients

Amyloid, 2021
Hereditary transthyretin (ATTRv) amyloidosis is caused by deposition of misfolded transthyretin protein, which aggregates in amyloid fibrils and disrupts several organs [1].
Gonçalo Videira, Diogo Pereira, Hugo Mota Dória, Ana Paula Sousa, Teresa Coelho, Ana Martins da Silva   +5 more
openaire   +2 more sources